Healthcare -
Biotechnology - NASDAQ - US
$ 37.67
0.106 %
$ 3 B
Market Cap
-10.05
P/E
AKRO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities AKRO - Akero Therapeutics, Inc.
-110 M
LAST VALUE
-31.11%
2 YEAR CAGR
-8.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR